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Review Article

Acute myocardial infarction triggered by influenza: Role of
vaccine in its prevention
Nischit Baral, Suman Sharma, Subash Ghimire, Sanjay Poudel, Savyata Hamal, Nisha Baral,
Niranjan Nayak *
Email: niruni2000@gmail.com

Abstract
Influenza is a major cause of hospitalization in all age groups. Cardiovascular complications due to influenza
are important causes of morbidity and mortality in the US, especially in the elderly population (aged more than
65 years). Acute Myocardial Infarction (AMI) is the most serious among the cardiovascular causes of mortality
following the attack of influenza, mainly in patients with various co-morbidities like pre-existing coronary
artery disease (CAD), diabetes mellitus (DM), hypertension (HTN) and heart failure (HF). We have reviewed the
association between influenza virus infection and AMI and extrapolated the beneficial effects of influenza vaccine
in preventing AMI and its grave consequences.
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Introduction
Influenza complications are important causes of
morbidity and mortality in many parts of the
world, especially in the elderly population (aged>
65 years). This seems to be on an increasing trend
with the increase in life expectancy in the aging
population1. Acute Myocardial Infarction (AMI) is
the leading cardiovascular complication of influenza
virus infection more importantly in the elderly and
the high-risk individuals2-4. According to the data
from CDC-Influenza Hospitalization Surveillance
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Network, there were 30,453 laboratory-confirmed
influenza-related hospitalizations between October
2017 and April 2018.The majority (58%) of
influenza-associated hospitalizations were in the
elderly age group5. Younger patients (age < 65 years)
were at risk of influenza-related complications only
in the setting of high-risk factors such as immunecompromised states, coronary artery disease (CAD),
heart failure (HF) exacerbations, hypertension
(HTN) and diabetes mellitus (DM)6. The purpose of
this article is to provide an updated review on the
potential of influenza virus infection as a trigger for
AMI and the role of vaccination in the prevention
of AMI associated hospitalization and mortality
and also to highlight the key areas where further
research is warranted.
Materials and methods
Data extraction
We searched Medline and Embase using relevant
Medical Subject Headings (MeSH) termed influenza
or influenza virus or flu or flu vaccine and myocardial
infarction or acute myocardial infarction or STEMI/
ACS or heart attack literature published within
the last five years with additional filters of human
studies and customized articles. The titles and
abstracts of all results were reviewed and studies
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were selected for full-text analysis according to their
eligibility criteria.
Eligibility criteria
We included human studies on AMI and influenza
or influenza vaccination in adults (age more than or
equal to18 years) for full-text analysis. We excluded
review articles and case reports.
Outcomes of interest
The primary outcome was AMI triggered by
influenza, including AMI hospitalizations and
mortalities. The role of vaccination in the prevention
of the above concomitances was examined in the
secondary outcome analysis.
Quality assessment and data extraction
Authors NBs and SS independently performed
the study selection, data extraction and quality
assessment.
Study characteristics
The search using the appropriate MeSH terms
yielded 1405 articles out of which 112 were relevant
and fulfilled our eligibility criteria. From these, we
excluded 99 articles and included only 13 for the
discussion according to the homogeneity of these
studies with ours (Flow chart depicted below). We

included data from CDC and other important studies
for the references. We also included high-quality
meta-analysis for the discussion regarding the role
of influenza vaccination in the prevention of AMI
associated hospitalization and death.
Discussion
Prevalence of influenza triggered AMI
Influenza is a trigger for AMI and ischemic heart
disease (IHD) particularly in the elderly population4,
7-9
. Warren-Gash et al10. performed a multicentre
prospective time series study in England, Wales and
Hong Kong and found that influenza was associated
with increased AMI related hospitalization and
death, suggesting this infection as an independent
risk factor for AMI10. This is further supported by an
observational study by Song et al. who too reported
that elderly patients suffering from influenza and
having other comorbidities such as DM, HF, preexisting CAD and HTN had higher in-hospital
cardiac mortality (fatal cardiac arrest and ventricular
arrhythmias) as compared to patients without these
risk factors11.
A similar association between infection due to
influenza virus and AMI was documented by Pearce
et al.8 and Kwong et al.4. Kwong et al. further
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substantiated that the influenza virus was a stronger
risk factor for the development of AMI than any
other virus causing acute respiratory tract infection4
A time series study by Nguyen et al. found that there
was a significant increase in all cause cardiovascular
mortality and AMI mortality during the influenza
outbreak12.
Guan and colleagues in the recent past stated that
cases of AMI were more likely to have positive IgG
antibodies to influenza virus A and B as compared
to controls; an observation which supported the
hypothesis that previous influenza virus infection had
a role to play in the development of atherosclerosis,
eventually triggering the occurrence of AMI13.
Pathogenesis of post-influenza AMI
The precise mechanism for the development
of AMI following influenza virus infection is
unclear. However, Naghavi et al. proposed that the
virus promoted atherosclerotic plaque formation
by inducing inflammation, smooth muscle cell
proliferation and fibrin deposition. Histological
analysis from the aortic sections of apolipoprotein
E-deficient mice injected with influenza A virus

showed marked proliferation of intimal epithelial
cells along with smooth muscle cells of tunica
media, which were filled with macrophages and T
lymphocytes, quite suggestive of atherosclerosis14.
Notwithstanding the above, the exact link between
the formation of atherosclerotic plaque and
influenza infection has not been clearly delineated.
MacIntyre et al. recently proposed that influenza
potentiated the release of inflammatory cytokines
which could give rise to a prothrombotic state15.
Further, influenza might have a direct effect on
the heart, producing local inflammatory changes,
as evidenced by histopathological and molecular
studies on influenza-infected mice16. Thus, a series
of studies conducted in the recent past, at various
centres supported the above-mentioned hypothesis
and these data have been presented vide Table 1.
Further studies are, however, needed to shed light on
this fascinating aspect of the pathogenesis of AMI
happening as a sequel of infection due to influenza
virus.

Table 1: Summary of reports depicting the role of influenza as a trigger for AMI
Study

Study design

Outcome

Exposure

Result (95% CI)

Kwong et
al.[4] 2018

Self-controlled caseseries design

AMI

Influenza A
Influenza B

IR= 10.11 (4.37-23.38)
IR= 5.17 (3.02-8.84)

WarrenGash et al.
2012 [17]

Self-controlled caseseries design

AMI

Influenza-like illness(ILI)
General acute respiratory
infection (ARI)

IR= 7.31 ( 2.72-19.64) p=0.26

Schwartz et Time series and
Mortality due
al.[18]
multivariate regression to AMI
model

Influenza

p< 0.001
p<0.002

WarrenGash et al.
2011[10]

AMI associated
mortality
AMI associated
hospitalizations

Seasonal influenza

3.1%-3.4% of 410, 204 MIassociated deaths (P < .001)
0.7%-1.2% of ≥1.2 million MIassociated hospitalizations (P < .001)

Foster et al. Time series
[3] 2013

AMI

Seasonal influenza and 2009
pandemic influenza

AMI AR not significant for person’s
age less than 65 years
AMI AR of 0.5% for those persons
over 65 years of age,
AMI AR of 0.85% for those persons
over 80 years

Guan et al.
[13] 2008

Presence of
IgG antibodies
of influenza

AMI

Compared to controls presence of
IgG to :
Influenza-A in cases:
Odds ratio (OR), 3.3; (95%CI),
1.5 to 7.4
Influenza-B in cases: Odds ratio
(OR), 17.2; (95%CI), 7.7 to 38.0

Time series

Case-control studies
comparing presence
of antibodies to
influenza A and B
among patients with
AMI (Cases) vs
those without AMI
(Controls)
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Seasonal influenza

IR= 4. 19 ( 3.18-5.53)
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IR: Incidence Ratio CAD: Coronary Artery Disease
AR: Attributable Risk
Can influenza vaccination prevent AMI and its
complications?
The proposed solution to prevent the AMI
hospitalizations and mortality following an attack
of influenza is prompt administration of influenza
vaccine. Huang et al. conducted a cohort study
and showed a significant reduction in the risk of
ischemic heart disease in elderly patients receiving
influenza vaccine19. A systematic review by Clar et
al. also showed that AMI was significantly reduced
after influenza vaccination20. In a prospective
randomized open-ended study by Phrommintikul
et al., influenza vaccination was shown to decrease
major cardiovascular hospitalizations due to AMI.
However, no significant difference was found in the
incidence of cardiovascular deaths among vaccine
recipient and non-recipient groups21.This is further
supported in a meta-analysis by Udell et al., who
reported that 42 of 3238 high risk patients (1.3%)
died of cardiovascular cause within one year of being
treated with influenza vaccine compared with 55 of
3231 high risk patients (1.7%) treated with placebo
(RR, 0.81 [95% CI, 0.36-1.83]; P = .61; I2 = 68%).
As the difference is statistically non-significant,
further studies are warranted to prove the
benefit of influenza vaccine in the prevention of
cardiovascular mortality, especially in high-risk
patients with previous acute coronary syndrome22.
However, vaccine, by preventing influenza and its
associated hospitalizations, in a way could prevent
the possibility of AMI triggered by the mechanisms
discussed above and also might prevent the associated
AMI related mortality.
In the light of the aforementioned ambiguity on
the effect of administration of influenza vaccine on
the prevention of AMI and its clinical outcome, it
could, thus, be advocated that further randomized
control trials would be needed to provide strong
evidences supporting the beneficial role of
vaccination against influenza in the prevention
of cardiovascular mortality. Consistent with the
above, a major multicentre prospective randomized
control trial entitled, ‘Influenza Vaccination after
Myocardial Infarction (IAMI Trial) NCT02831608’,

based on the Swedish Angiography and Angioplasty
Registry (SCAAR) platform is ongoing to give us
the insight on in-hospital influenza vaccination and
cardiovascular outcomes in patients with AMI23.
Conclusions
Many studies in the past put forth the view that
influenza virus infection was a trigger for AMI24.
Though the role of influenza virus in the initiation
of AMI was proven by a number of investigations
and the risk for AMI was found to be higher with
infection due to influenza virus as compared to
those due to other respiratory viruses4, yet data
exhibiting concrete evidences in favour of the
causal role of the influenza virus in giving rise to
AMI are still lacking. Influenza vaccination could
play a protective role in the occurrence of influenzaassociated hospitalization and mortality due to
AMI. Hence, vaccination should be encouraged to
prevent cardiovascular complications and mortality
especially among high-risk and elderly patients20-25.
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